Suzhou Osai Biopharma Celebrates Successful Phase III Clinical Trial for Lactobacillus Crispatus Live Bacteria Capsule: A Breakthrough in Reducing Recurrence of Gynecological Infections
Suzhou OSAI Biopharma Announces Successful Phase III Clinical Trial Results Breaking News in Biopharmaceuticals Suzhou OSAI Biopharma, Inc., a leading biopharmaceutical company specializing in live biotherapeutic products (LBPs), has just revealed the exciting results of its Phase III clinical trial. The trial centered around the use of vaginal L. crispatus live bacteria capsule (Lc262-1) and…